Humacyte Investor Relations Material
Latest events
Status Update
Humacyte
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Humacyte Inc
Access all reports
Humacyte, Inc. engages in developing, manufacturing and commercializing products for off-the-shelf therapy. The company focuses on solid tumors, benign bone growths, and vascular disease. It also manufactures human tissue for other therapies. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States